Evidence map›Paper›PMID 34025211›Full record

ArticleSoft computing2023

Simple hemogram to support the decision-making of COVID-19 diagnosis using clusters analysis with self-organizing maps neural network.

Alexandra A de Souza, Danilo Candido de Almeida, Thiago S Barcelos, Rodrigo Campos Bortoletto, Roberto Munoz, Helio Waldman, Miguel Angelo Goes, Leandro A Silva

RetractedAbstract readRetracted Publication
In one paragraph

Article in Soft computing, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Alexandra A de SouzaLaboratory of Applied Computing - LABCOM3, Federal Institute of Education, Science and Technology of São Paulo, São Paulo, Brazil.ORCID 0000-0001-9939-9207
Danilo Candido de AlmeidaNephrology Division - Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Thiago S BarcelosLaboratory of Applied Computing - LABCOM3, Federal Institute of Education, Science and Technology of São Paulo, São Paulo, Brazil.
Rodrigo Campos BortolettoLaboratory of Applied Computing - LABCOM3, Federal Institute of Education, Science and Technology of São Paulo, São Paulo, Brazil.
Roberto MunozEscuela de Ingeniería Informática, Universidad de Valparaíso, Valparaíso, Chile.
Helio WaldmanDepartment of Communications, FEEC Unicamp, Campinas, SP Brazil.
Miguel Angelo GoesNephrology Division - Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Leandro A SilvaLaboratory of Big Data and Applied Analytical Methods - Big MAAp, Mackenzie Presbiterian University, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is related to new coronavirus disease (COVID-19) has mobilized several scientifics to explore clinical data using soft-computing approaches. In the context of machine learning, previous studies have explored supervised algorithms to predict and support diagnosis based on several clinical parameters from patients diagnosed with and without COVID-19. However, in most of them the decision is based on a "black-box" method, making it impossible to discover the variable relevance in decision making. Hence, in this study, we introduce a non-supervised clustering analysis with neural network self-organizing maps (SOM) as a strategy of decision-making. We propose to identify potential variables in routine blood tests that can support clinician decision-making during COVID-19 diagnosis at hospital admission, facilitating rapid medical intervention. Based on SOM features (visual relationships between clusters and identification of patterns and behaviors), and using linear discriminant analysis , it was possible to detect a group of units of the map with a discrimination power around 83% to SARS-CoV-2-positive patients. In addition, we identified some variables in admission blood tests (Leukocytes, Basophils, Eosinophils, and Red cell Distribution Width) that, in combination had strong influence in the clustering performance, which could assist a possible clinical decision. Thus, although with limitations, we believe that SOM can be used as a soft-computing approach to support clinician decision-making in the context of COVID-19.

Indexed as

Covid-19 diagnosticSARS-CoV-2Self-organizing maps

Identifiers

PMID34025211
PMCPMC8127503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.